Medicine and Dentistry
Patient
100%
Radiation Therapy
89%
Lung Cancer
65%
Non Small Cell Lung Cancer
53%
Therapeutic Procedure
41%
Small Cell Lung Cancer
38%
Inpatient
27%
Chemoradiotherapy
22%
Survival
21%
Neoplasm
21%
Diseases
18%
Overall Survival
18%
Chemotherapy
15%
Analysis
15%
Heart
14%
Non-Small Cell Lung Cancer
13%
Brain Metastasis
12%
Toxicity
12%
Prophylactic Cranial Irradiation
11%
Surgery
10%
Lung
10%
Consensus
9%
Durvalumab
9%
Quality of Life
9%
Development
9%
Radiation
8%
Death
7%
Arm
7%
Age
7%
Whole Brain Radiotherapy
7%
Intensity Modulated Radiation Therapy
7%
Cancer Radiotherapy
6%
Irradiation
6%
Association
6%
Magnetic Resonance Imaging
6%
Obstetric Delivery
6%
Radiation Oncology
6%
Enalapril Maleate
6%
Cells
6%
Drug Megadose
5%
Biological Marker
5%
Cancer Treatment
5%
Organ
5%
Randomized Controlled Trial
5%
Evaluation Study
5%
Clinical Trial
5%
COVID-19
5%
Malignant Neoplasm
5%
Pleura Mesothelioma
5%
Hazard Ratio
5%
Pharmacology, Toxicology and Pharmaceutical Science
Non Small Cell Lung Cancer
28%
Lung Cancer
18%
Chemoradiation Therapy
17%
Small Cell Lung Cancer
13%
Neoplasm
10%
Radiation
8%
Survival
8%
Durvalumab
8%
Chemotherapy
7%
Overall Survival
6%
Diseases
6%
Biological Marker
5%
Toxicity
5%
Nursing and Health Professions
Lung Cancer
16%
Radiotherapy
16%
Patient
14%
Non Small Cell Lung Cancer
10%
Patient-Reported Outcome
6%
Survival
6%
Chemoradiotherapy
5%
Durvalumab
5%
Dose
5%